{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:06:47Z","timestamp":1784120807654,"version":"3.55.0"},"reference-count":35,"publisher":"JLE","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.nephro.2018.02.018","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T15:31:26Z","timestamp":1522337486000},"page":"S39-S50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S1","title":["\u00c9tude des \u00e9tiologies sp\u00e9cifiques de perte des greffons r\u00e9naux\u00a0: place du rejet m\u00e9di\u00e9 par les anticorps et approche en population"],"prefix":"10.1684","volume":"14","author":[{"given":"Charlotte","family":"Loh\u00e9ac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Loupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2018.02.018_bib0180","series-title":"Le rapport annuel m\u00e9dical et scientifique 2015","author":"Anon","year":"2015"},{"issue":"9","key":"10.1016\/j.nephro.2018.02.018_bib0185","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198502283120905","article-title":"The quality of life of patients with end-stage renal disease","volume":"312","author":"Evans","year":"1985","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nephro.2018.02.018_bib0190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ndt\/gfp469","article-title":"Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly","volume":"25","author":"Bayat","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.nephro.2018.02.018_bib0195","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1681\/ASN.2004121092","article-title":"Impact of cadaveric renal transplantation on survival in patients listed for transplantation","volume":"16","author":"Oniscu","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.nephro.2018.02.018_bib0200","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1600-6143.2004.00573.x","article-title":"Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2018.02.018_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gfq730","article-title":"Kidney allograft survival: the long and short of it","volume":"26","author":"Lodhi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"9470","key":"10.1016\/j.nephro.2018.02.018_bib0210","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.nephro.2018.02.018_bib0215","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1001\/jama.294.21.2726","article-title":"Deceased-donor characteristics and the survival benefit of kidney transplantation","volume":"294","author":"Merion","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2018.02.018_bib0220","doi-asserted-by":"crossref","first-page":"h3557","DOI":"10.1136\/bmj.h3557","article-title":"Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study","volume":"351","author":"Aubert","year":"2015","journal-title":"BMJ"},{"issue":"9185","key":"10.1016\/j.nephro.2018.02.018_bib0225","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(99)01104-6","article-title":"Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA)","volume":"354","author":"Morris","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.nephro.2018.02.018_bib0230","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/TP.0000000000001351","article-title":"The impact of total ischaemic time, donor age and the pathway of donor death on graft outcomes after deceased donor kidney transplantation","volume":"101","author":"Wong","year":"2017","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.nephro.2018.02.018_bib0235","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nephro.2018.02.018_bib0240","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2018.02.018_bib0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015\u00a0Kidney Meeting report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.nephro.2018.02.018_bib0250","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.nephro.2018.02.018_bib0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.nephro.2018.02.018_bib0260","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.nephro.2018.02.018_bib0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-6143.2002.20301.x","article-title":"Call for revolution: a new approach to describing allograft deterioration","volume":"2","author":"Halloran","year":"2002","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.nephro.2018.02.018_bib0270","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1681\/ASN.2014060588","article-title":"Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients","volume":"26","author":"Halloran","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"10.1016\/j.nephro.2018.02.018_bib0275","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies","volume":"13","author":"El Ters","year":"2013","journal-title":"Am J Transplant"},{"issue":"13","key":"10.1016\/j.nephro.2018.02.018_bib0280","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"issue":"9863","key":"10.1016\/j.nephro.2018.02.018_bib0285","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.nephro.2018.02.018_bib0290","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation."},{"issue":"4","key":"10.1016\/j.nephro.2018.02.018_bib0295","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1600-6143.2005.01230.x","article-title":"Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss","volume":"6","author":"Moreso","year":"2006","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.nephro.2018.02.018_bib0300","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/TP.0000000000000148","article-title":"Predictive patterns of early medication adherence in renal transplantation","volume":"98","author":"Nevins","year":"2014","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.nephro.2018.02.018_bib0305","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2018.02.018_bib0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31823bb647","article-title":"Early subclinical rejection as a risk factor for late chronic humoral rejection","volume":"93","author":"Moreso","year":"2012","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.nephro.2018.02.018_bib0315","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.nephro.2018.02.018_bib0320","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2215\/CJN.00770112","article-title":"Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients","volume":"7","author":"Sharif","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.nephro.2018.02.018_bib0325","first-page":"297","article-title":"Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature","volume":"8","author":"Soleymanian","year":"2010","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"10.1016\/j.nephro.2018.02.018_bib0330","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.2016020126","article-title":"Kidney transplantation outcomes across GN subtypes in the United States","volume":"28","author":"O'Shaughnessy","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.nephro.2018.02.018_bib0335","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1600-6143.2009.02580.x","article-title":"Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study","volume":"9","author":"Canaud","year":"2009","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.nephro.2018.02.018_bib0340","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.nephro.2018.02.018_bib0345","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/ajt.13162","article-title":"Early graft loss after kidney transplantation: risk factors and consequences","volume":"15","author":"Hamed","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.nephro.2018.02.018_bib0175","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/ctr.12750","article-title":"Renal allograft thrombosis after living donor transplantation: risk factors and obstacles to retransplantation","volume":"30","author":"Adler","year":"2016","journal-title":"Clin Transplant"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725518300397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725518300397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2018.02.018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:12:40Z","timestamp":1741191160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725518300397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"alternative-id":["S1769725518300397"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2018.02.018","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tude des \u00e9tiologies sp\u00e9cifiques de perte des greffons r\u00e9naux\u00a0: place du rejet m\u00e9di\u00e9 par les anticorps et approche en population","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2018.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}